In 2025, it will be impossible not to make training in the pharmaceutical industry an essential component of pharmaceutical company strategy. French reindustrialization, increasing global competition, changing standards, waves of recruitment and production rates are all factors demanding operational excellence. In this fluctuating context, team training consolidates the pillars of pharmaceutical production: innovation and quality. As an expert in supporting executives, managers and operational staff in pharmaceutical manufacturing, I present in this article the 5 points that make training the key to your performance.
Training must be seen as the cornerstone of quality, because by implementing it, a pharmaceutical company will be able to :
The ever-changing nature of regulations (GMP, ICH, revision of EU pharmaceutical legislation, etc.) keeps pace with the adjustments that drug manufacturers have to make. In recent years, for example, regulatory changes have responded to a number of constraints:
Training guarantees the harmonization of legislative knowledge among teams at all levels of drug production, and removes the burden of financial penalties resulting from ANSM injunctions.
Staff training is an integral part of the quality process, as it is an essential lever in the error prevention process.
At a time when the French government is mentioning healthcare and biotechnology as a sector with a promising future in terms of jobs by 2030, Leem’s article, La place de la France dans la production de médicaments, questions France’s current sovereignty in the field of biotechnological innovations. According to the organization, “it is essential to diversify production by integrating more innovative drugs and adopting new technologies”.
This strategy implies, as of today, a rethinking of the innovations themselves, as well as work on the teams required to cope with the changes.
Quality risk management (ICH Q9) represents an entire chapter of GMP. A standardized methodology is required to
Training is also an important criterion in CSR policies. Its implementation promotes well-being in the workplace by acting on :
Our training catalog covers all aspects of the pharmaceutical quality system: GMP, quality management, data integrity, risk analysis, qualification and validation, etc. Take advantage of LUGAN CONSULTING’s expertise, thanks to entertaining curricula tailored to your day-to-day professional life. Each of our 10 themes addresses a specific issue and aims to achieve several objectives:
How to ensure compliance of operations in a GMP environment?
Identify the risks applicable to your department’s activities.
How to guaranteedata integrity in a GMP environment?
How to successfully implement an ICH Q9 risk analysis approach
How to analyze and prevent the risk of human error in a GMP environment?
How to guarantee the conformity of operations in a GMP environment?
To obtain details
of LUGAN CONSULTING training sessions,
download our catalog :
Send download link to:
Audit methodology and techniques in the pharmaceutical industry
How to set up an effective knowledge management process in a GMP environment?
How to set up an efficient Change Control process in a GMP environment?
How can you optimize your processes with Lean Management?
How to solve a problem effectively?
Training is the driving force behind the performance of successful pharmaceutical companies. By investing in the skills development of its employees, a pharmaceutical company strengthens its competitiveness, improves its productivity, preserves its reputation and retains its talent. Training employees is the first strategic lever for achieving these objectives.
We can tailor programs to meet your specific challenges and those of your team. Contact Frank Lugan for a training program tailored to your company’s specific needs.